论文部分内容阅读
脑卒中的超早期治疗专辑──血栓噁烷合成酶抑制剂与超早期治疗平井俊策血栓烷Ａ２（ｔｈｒｏｍｂｏｘａｎＡ２，ＴＸＡ２）合成酶抑制剂是针对缺血性脑血管障碍的药物，所以治疗对象为脑卒中的脑梗塞病例。目前尚无单纯以脑梗塞超早期为对象用ＴＸＡ２合成酶抑制剂治疗的...
Ultra-Early Stroke Treatment Album - Thromboxane A Synthase Inhibitors and Ultra-Early Treatment HITACHI Toshiaki A Thromboxane A2 (TXA2) Synthase Inhibitor is a drug that targets ischemic cerebrovascular disorders and therefore targets the brain Stroke cerebral infarction cases. At present, there is no simple treatment of TXA2 synthase inhibitors for the early stage of cerebral infarction.